Hubei Hongyuan Pharmaceutical Technology Co., Ltd., the common stock will be listed in this exchange on March 20, 2023. Hubei Hongyuan Pharmaceutical Technology Co., Ltd. is located in Luotian County at the southern foot of Dabie Mountain. It is a quality AAAA credit enterprise in China and one of the top 100 chemical and pharmaceutical enterprises in China. China chemical pharmaceutical industry raw materials export-oriented excellent enterprise brand, national high-tech enterprises. Leading enterprises in agricultural industrialization in Hubei Province, enterprises that honor contracts and keep promises in Hubei Province. Top Ten Enterprises in Hubei Pharmaceutical Industry, Golden Crane Award for Excellent Enterprises in Hubei Province, Fourth Dabie Mountain Quality Award in Huanggang City, First Top Ten Charity Private Enterprises in Huanggang City, Golden Eagle Award for Excellent Enterprises in Huanggang City. Innovation System Company is an innovative enterprise in Hubei Province, cooperating with Tsinghua University, Fudan University, Wuhan University, Huazhong University of Science and Technology, Sichuan University, Wuhan University of Technology and Hubei University of Traditional Chinese Medicine. * * * Colleges and universities set up pharmaceutical and chemical research institutions, including provincial-level enterprise technology centers recognized by Hubei Science and Technology Department, Hubei Fluorine Chemical Technology Research Center, and Dabie Mountain Experimental Area featured agricultural products R&D Center. A relatively complete technological innovation system has been formed, with more than 50 invention patents, utility model patents and design patents. There are many core technologies with independent intellectual property rights in raw materials and basic chemicals, and their innovative processes have won provincial scientific and technological progress awards for many times. During the "Thirteenth Five-Year Plan" period, the company will take Chinese medicine, western medicine preparations, food and feed additives, new energy, polymer materials and other industries as the development direction, and strive to build a new pharmaceutical enterprise of 10 billion yuan.